Tool Calling and Plugins for Rare Disease Pharmacovigilance

Rare disease pharmacovigilance data comes from various sources. These include global drug regulatory reports, medical literature, clinical trial data

Data Characteristics in This Category

Rare disease pharmacovigilance data comes from various sources. These include global drug regulatory reports, medical literature, clinical trial data, patient registries, and social media information. Data update frequencies vary. Regulatory reports might be quarterly or annually, while medical literature and social media can update in real-time or near real-time. Document structures are mostly unstructured or semi-structured text, such as case reports, clinical study abstracts, and patient self-reports. Specificity in fields and units is common. Disease manifestations, drug dosages, and adverse reaction descriptions often involve highly specific medical terminology and measurement units, like micrograms per kilogram of body weight or International Units (IU). The same concept can also have multiple synonyms or abbreviations.

Constraints Imposed by These Characteristics on "Tool Calling and Plugins"

The heterogeneity and varying update frequencies of rare disease data sources demand highly flexible and multi-source integration capabilities for tool calling. The model must identify and parse information from different document formats. For example, it needs to extract key adverse events from PDF regulatory reports or scrape patient forum discussions from web links. The specificity and diversity of medical terminology challenge the semantic understanding and entity recognition capabilities of plugins. Plugins must accurately match disease, drug, and adverse reaction entities under different expressions to avoid misjudgment or omissions. Additionally, asynchronous data updates mean tool calling strategies must balance timeliness and data completeness. For instance, prioritize real-time data sources for urgent adverse events, but integrate historical data for trend analysis.

Configuration Settings

Configuration ItemRecommended ValueRationale
tool_retrieval_top_k5–8Ensures the model retrieves enough relevant tools for complex queries, addressing the breadth of rare disease data sources.
max_token_per_tool_output2000–3000Rare disease documents often contain extensive medical details. This range covers complete information from most tool outputs.
plugin_timeout_seconds60 secondsMost external API response times are reasonable. This setting prevents long waits while allowing for complex queries.
entity_extraction_modelFine-tuned Model for Specific Medical FieldsRare diseases have unique medical terminology. General models lack sufficient accuracy, requiring specialized model support.
data_source_priority_configCalibrate by actual measurementDynamically adjusts tool calling priority based on factors like data source timeliness, authority, and information density.

Three Common Mistakes

  • The model fails to call the expected plugin, returning a generic answer or an error like No tool found for query. This happens when the model's understanding of the query intent does not sufficiently match the plugin description, or the plugin description is too vague, failing to clearly define its functional boundaries.
  • Plugin execution times out, with logs showing Tool execution timed out after 60 seconds. This usually occurs due to slow external API responses, or complex internal processing logic and large data volumes within the plugin, leading to lengthy computations.
  • Key medical entity fields are empty or incomplete in the tool's output. This results from document parsing failures, insufficient performance of the entity recognition model, or changes in document structure preventing the parser from correctly extracting information.

How to Verify Configuration

  • Execute queries for various rare disease names and drug combinations. Verify if the model accurately calls the pre-configured pharmacovigilance plugins.
  • Simulate queries containing complex medical terms and abbreviations. Check if key adverse reactions, dosages, and disease manifestations in the plugin output are complete and accurate.
  • Randomly select rare disease pharmacovigilance reports in different formats (e.g., PDF, web pages). Attempt to parse them via tool calls. Verify if the model successfully extracts core information from the reports.
  • Observe whether tool calls prioritize the latest or most authoritative data based on the data source priority configuration, especially with varying data update frequencies.

The values provided are common starting points. They should be measured against specific samples and use cases.

Question material comes from public community discussions. Configuration values are common starting points and should be measured against your own samples. Verified on 2026-09-21.